R&D Alzheimer's research is moving toward more selective targets As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.
News FDA greenlights Roche’s biomarker blood test for Alzheimer's Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.
News Philanthropists donate $30m towards finding Alzheimer’s cure A coalition of philanthropists has announced they are donating more than $30 million in a drive to combat Alzheimer’s disease.
News Click claims FDA okay for first-in-class schizophrenia DTx Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
